Documents
Application Sponsors
Marketing Status
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 400MG | 0 | NEVIRAPINE | NEVIRAPINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2015-10-15 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2019-08-14 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2019-08-14 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 3 | Null | 15 |
SUPPL | 5 | Null | 15 |
CDER Filings
CIPLA
cder:Array
(
[0] => Array
(
[ApplNo] => 206448
[companyName] => CIPLA
[docInserts] => ["",""]
[products] => [{"drugName":"NEVIRAPINE","activeIngredients":"NEVIRAPINE","strength":"400MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"10\/15\/2015","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/206448Orig1s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"10\/15\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/206448Orig1s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/206448Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] => [{"actionDate":"08\/14\/2019","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"08\/14\/2019","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"08\/14\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert, Labeling-Medication Guide","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2019-08-14
)
)